期刊文献+

刺桐胰蛋白酶抑制剂亲和填料的制备及纯化瑞替普酶

Reteplase Purification by Erythrina Trypsin Inhibitor Affinity Chromatograpy
下载PDF
导出
摘要 刺桐属胰蛋白酶抑制剂 (ETI)是一种丝氨酸蛋白酶抑制剂 ,能特异性的抑制胰蛋白酶、组织纤溶酶原激活剂 (t PA)、瑞替普酶 (r PA)等丝氨酸蛋白酶。实验利用ETI工程菌 ,经诱导表达、体外复性及纯化获得ETI蛋白 ,并将该蛋白键合到CNBr活化的琼脂糖凝胶 ,制备ETI亲和填料 。 Erythrina trypsin inhibitor (ETI), Which belongs to serine proteinase inhibitor, has the ability to bind to and inhibit trypsin 、 tissue plasminogen activator or reteplase (BM.06 022). With E.coli cells harboring the recombinant plasmid, the ETI protein was expressed, renaturated and purified,then was conjugated to CNBr activated sepharose 4B to prepare an affinity chromatography column, which purify reteplase successfully.
出处 《中国生物工程杂志》 CAS CSCD 2003年第6期87-89,共3页 China Biotechnology
关键词 刺桐胰蛋白酶抑制剂 亲和填料 制备 瑞替普酶 Erythrina trypsin inhibitor\ Affinity chromatography\ Reteplase
  • 相关文献

参考文献8

  • 1奥斯伯F 布伦特R.金斯顿R E.等.《精编分子生物学实验指南》[M].北京:科学出版社,1998.332—333.
  • 2萨姆布鲁克J.弗里奇EF 曼尼阿蒂斯T.《分子克隆实验指南》,第二版[M].北京:科学出版社,1992.845—848.
  • 3陈黄实,任启生,宋新荣,黄子才.刺桐属胰蛋白酶抑制剂的结构与生物活性关系[J].生物技术通讯,2002,13(3):222-225. 被引量:7
  • 4Kohnert V. Rvdolph R. Verheijen J H. et al. Biochemical properties of the kringle-2 and protease domains are maintained in the refolded t-Pa deletion variant BM 06.022. Protein. Eng. 1992.5:93 - 100.
  • 5Joubert F .I, Doudle E B. The primary structure of the Inhibitor of tissue plaminogen activator found in the seeds of erythrina caffra.Thrombosis and Haemostasis, 1987,57 : 356 - 360.
  • 6Minuth T. Kramer B, Lehle K, et al. The spetroscopie analysis inhibition and binding studies demonstrate the equivalence of erythrina caffra trypsin inhibitor and the recombinant substitution variant recSerETI. Journal of Biotechnology, 1998,62: 231 - 239.
  • 7Erlanger B F, Kokowsky N, Cohen W. The preparation and properties of two new chromogenic substrates of trypsin. Arch Biochem Biophys, 1961,95:271 - 278.
  • 8Walsh K A, Wilcox, P E. Sefine proteases. Methods Enzymol,1970,19:31 - 41.

二级参考文献36

  • 1Joubert FJ. Proteinase inhibitors from Erythrina lysistemon seed [J]. Phytochemistry, 1982,21:1213
  • 2Joubert FJ. Proteinase inhibitors from Erythrina abyssinnica and Erythrina decora seed[J]. S Afr J Chem, 1986,39:169
  • 3Joubert FJ,Carlsson FHH and Haylett T. Purification and some properties of two proteinase inhibitors (DE-1 andDE-3) from Erythrina latissima seed Hoppe-Seyler's Z [J]. Physiol Chem, 1981,362:531
  • 4Jouber FJ, Heussen C and Dowdle EBD. The Complete amino acid sequence of trypsin inhibitor DE-3 from Erythrina latissima seeds[J]. J Biol Chem, 1985,260:12948
  • 5Jouber FJ and Sharon N. Proteinase inhibitors from Erythrina corallodendron and Erythrina cristagalli seeds[J]. Phytochemistry,1985,24:1169
  • 6Heussen C, Joubert F and Dowdle EB. Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor[J]. J Biol Chem, 1984,259:11635
  • 7Francois J, Joubet EH. The reactive sites inhibitrosfrom Erythrina seeds[J]. Int J Biochem, 1987,1
  • 8Kohnert V,Rvdolph R, Verheijen JH, et al. Biocoperties of the Kringle 2 and protease domains are inthe refolded t-Pa deletion variant BM 06.022[J]. Protein Eng. 1992,5:93
  • 9Leuag D, Abbenante G and David PF. Protease inhibitors: cur rent status and future prospects [J]. J Medicinal Chemistry, 2000,43(3):305
  • 10Christa HS, Edwn HM and Eugene BDD. The Erythrina protease inhibitor: interactions with tisue plasminogen activator [J].Thrombsis and Haemostasis, 1991,66(2):226

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部